Resistensi dari bakteri enterik: aspek global terhadap antimikroba

Main Article Content

Yenny Yenny
Elly Herwana

Abstract

Resistensi antimikroba dari bakteri merupakan suatu masalah kesehatan masyarakat yang sifatnya global. Masalah ini menjadi bertambah penting dalam hal pengobatan infeksi enterik. Di negara-negara berkembang resistensi terhadap obat-obat lapis pertama (first-line drugs) telah dijumpai di antara luman-kuman patogen enterik, yang disebabkan oleh penggunaan antimikroba yang semena-mena. Pada beberapa kasus, derajat resistensi memaksa digunakannya obat-obat lapis kedua dan ketiga, yang harganya lebih mahal. Situasi ini juga mengancam timbulnya resistensi terhadap golongan obat-obat antimikroba golongan ini yang pada akhirnya menyebabkan beban ekonomi yang besar dan resistensi multipel. Di banyak negara berkembang, data mengenai prevalensi resistensi antimikroba sedikit sekali ditemukan. Kurangnya fasilitas laboratorium merupakan kendala besar dalam mengembangkan surveilans yang efektif. Untuk mempertahankan jangka efektivitas suatu antimikroba, khususnya di negara berkembang, perlu dilakukan perbaikan sistem surveilans untuk memantau timbulnya resistensi antimikroba, perbaikan akses laboratorium, peraturan penggunaan antimikroba yang lebih baik, dan pendidikan masyarakat.

Article Details

How to Cite
Yenny, Y., & Herwana, E. (2007). Resistensi dari bakteri enterik: aspek global terhadap antimikroba. Universa Medicina, 26(1), 46–56. https://doi.org/10.18051/UnivMed.2007.v26.46-56
Section
Review Article

References

Shears P. Antibiotic resistance in the tropics. Trans Roy Soc Trop Med Hyg 2001; 95: 127-30.

Departemen Kesehatan RI. Survei Kesehatan Nasional 2001. Laporan SKRT 2001: studi morbiditas dan disabilitas. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2002.

Departemen Kesehatan RI. Survei Kesehatan Nasional 2001. Laporan studi mortalitas 2001: pola penyakit penyebab kematian di Indonesia. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2002.

Oyofo BA, Lesmana M, Subekti D, Tjaniadi P, Larasati W, Putri M, et al. Surveillance of bacterial pathogens of diarrhea disease in Indonesia. Diagn Microbiol Infect Dis 2002; 44: 227-34.

Conly J. Antimicrobial resistance in Canada. CMAJ 2002; 167: 885-91.

Kariuki S, Hart A. Global aspects of antimicrobial-resistant enteric bacteria. Curr Opin Infect Dis 2001; 14: 579-86.

Millar MR, Walsh TR, Linton CJ. Carriage of antibiotic-resistant bacteri by healthy children. J Antimicrob Chemother 2001; 47: 605-10.

Taremi M, Mehdi SDM, Gachkar L, MoezAdralan S, Zolfagharian K, Reza ZM. Prevalence and antimicrobial resistance of Campylobacter isolated from retail raw chicken and beef meat, Tehran, Iran. Int J Food Microbiol 2006; 108: 401-3.

Boonmar S, Sangsuk L, Suthivarakom K, Padungtod P, Morita Y. Serotypes and antimicrobial resistance of Campylobacter jejuni isolated from humans and animals in Thailand. Southeast Asian J Trop Med Public Health. 2005; 36: 130-4.

Griggs DJ, Johnson MM, Frost JA, Humphrey T, Jorgensen F, Piddock LJ. Incidence and mechanism of Ciprofloxacin resistance in Campylobacter spp. Isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrob Agents and Chemother 2005; 49: 699-707.

Inglis GD, McAllister TA, Busz HW, Yanke LJ, Morck DW, Olson ME, et al. Effect of subtherapeutic administration of antimicrobial agents to beef cattle on the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter hyointestinalis. Appl Environ Microbiol 2005; 71: 3972-81.

FDA. Human health impact of fluoroquinolone resistant Campylobacter jejuni infection attributed to the consumtion of chicken. Washington DC: United States Federal Drugs Administration; 2000.

Waldenstrom J, Mevius D, Veldman K, Broman T, Hasselquist D, Olsen B. Antimicrobial resistance profiles of Campylobacter jejuni isolates from wild birds in Sweden. Appl Environ Microbiol 2005; 71: 2438-41.

Parry CM. Antimicrobial drug resistance in Salmonella enterica. Curr Opin Infect Dis 2003; 16: 467-72.

Islam A, Butler T, Kabir I, Alam NH. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized controlled trial. Antimicrob Agents Chemother 1993; 37: 1572-5.

Mirza SH, Beeching NJ, Hart CA. multi-drug resistant typhoid: a global problem. J Med Microbial 1996; 44: 317-19.

Sanborn WR, Lesmana M, Dennis DT, Trenggonowati R, Kadirman, Lita I, et al. Antibiotic resistant typhoid in Indonesia. Lancet 1975; ii: 408-9.

Lee K, Yong D, Yum JH. Lim YS, Kim HD, Lee BK, Chong Y. Emergence of Multidrug-resistant Sallmonella enterica serovar Typhii in Korea. Antimicrob Agents Chemother 2004; 48: 4130-5.

Kariuki S, Revathi G, Muyodi J, Mwituri J, Munyalo A, Mirza S, et al. Characterization of mulridrug-resistant thyphoid outbreaks in Kenya. J Clin Microbiol 2004; 42: 1477-82.

Akinyemi KO, Smith SI, Oyefolu AO, Coker AO. Multidrug resistance in Sallmonella enterica serovar Typhi isolated from patients with typhoid fever complication in Lagos, Nigeria. Public Health 2005; 119: 321-7.

Mohanty S, Renuka K, Sood S, DAS BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 14:1-6.

Mermin JH, Villar R, Carpenter J, Robert L, Samaridden A, Gasanova L, et al. A massive epidemic of multi-drug resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis 1999; 179: 1416-22.

Niyogi SN. Shigellosis. J Microbiol 2005; 43: 133-43.

Garg P, Cakraborty S, Basu I. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect 2000; 94: 323-26.

Taneja N, Mohan B, Khurana S, Sharma M. Antimicrobial resistance in selected bacterial enteropathogen in North India. Indian J Med Res 2004; 120: 39-43.

Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005; 18: 465-83.

Oyono BA,Subekti D, Tjaniadi P, Machpud N, Komalarini S, Setiawan B. Enteropathogen associated with acute diarrhea in community and hospital patient in Jakarta, Indonesia. FEMS Immunol Med Microbiol 2002; 34: 139-46.

Tjaniadi P, Lesmana M, Subekti D, Machpud N, Komalarini S, Santoso W, et al. Antimicrobial resistance of bacterial pathogen associated with diarrhea patients in Indonesia. Am J Trop Hyg 2003; 68: 666-70.

Subekti DS, Lesmana M, Tjaniadi P, Machpud N, Sriwati, Sukarma, et al. Prevalence of enterotoxigenic Escherichia coli (ETEC) in hospitalized acute diarrhea patients in Denpasar, Bali, Indonesia. Diagn Microbiol Infect Dis 2003; 47: 399-405.

Agtini MD, Rooswanti S, Lesmana M, Punjabi NH, Simanjuntak S, Wangsaputra F, et al. The burden of diarrhea, shigellosis dan cholera in North Jakarta, Indonesia: findings from 24 month surbeillance. BMC Infect Dis 2005; 5: 89: 1-11.